Please use this identifier to cite or link to this item:
Title: Intracellular binding is an important determinant of the avid hepatic uptake of the high clearance drug omeprazole.
Austin Authors: Sewell, Richard B;Brook, C W;Mihaly, G W;Morgan, Denis J;Smallwood, R A
Affiliation: Gastroenterology Unit, Austin Hospital, Melbourne, Victoria, Australia
Issue Date: 17-Aug-1994
Publication information: Biochemical Pharmacology; 48(4): 846-9
Abstract: The contribution of intracellular storage to hepatic uptake of the high clearance drug, omeprazole, was examined in the recirculating isolated perfused rat liver preparation. Following injection of [3H]omeprazole (7.5 microCi, 5 mg) into the portal vein over 1 min, livers were perfused for 5 min (N = 3) or 30 min (N = 3) and then homogenized at 4 degrees and fractionated by differential centrifugation. Radiolabelled omeprazole and metabolites were determined by scintillation counting of fractions of eluant from HPLC. Seventy per cent of drug had been taken up by the liver at 5 min and 85% at 30 min, with unchanged drug representing 43 and 7.4%, respectively, of drug taken up. At both times, 70-75% of intracellular unchanged drug and the major metabolites were located in the cytosol, and the cytosol:perfusate concentration ratio was approximately 10:1. Mitochondrial, lysosomal and microsomal fractions contained relatively little drug. Extensive cytosolic binding of omeprazole therefore contributes substantially to the initial avid hepatic first-pass uptake of this drug.
Gov't Doc #: 8080458
Journal: Biochemical pharmacology
Type: Journal Article
Subjects: Animals
Omeprazole.administration & dosage.metabolism.pharmacokinetics
Portal Vein
Rats, Sprague-Dawley
Subcellular Fractions.metabolism
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Jan 30, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.